<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00691327</url>
  </required_header>
  <id_info>
    <org_study_id>910044</org_study_id>
    <nct_id>NCT00691327</nct_id>
  </id_info>
  <brief_title>Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants</brief_title>
  <official_title>Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Allergan Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Allergan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Safety and effectiveness of Natrelleâ„¢ Cohesive Round Silicone-Filled Breast Implants in women
      undergoing primary reconstruction or revision of existing breast implants.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 1997</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Local Complications</measure>
    <time_frame>5 years</time_frame>
    <description>By patient risk of complications occurring in at least 5% of patients in 1 or more cohorts</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale</measure>
    <time_frame>5 years</time_frame>
    <description>Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">84329</enrollment>
  <condition>Breast Reconstruction</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Primary reconstruction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Revision-reconstruction</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Revision-augmentation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Natrelle(TM) Silicone-Filled Breast Implants</intervention_name>
    <description>Breast implant surgery</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females of any age for which breast reconstruction is considered appropriate (Patients
             under 18 years old require parental/legal guardian consent to participate.

          -  Females seeking revision augmentation or revision reconstruction, where problems exist

          -  Have any of the following conditions or situations present:

          -  Post mastectomy surgical removal of the breast for cancer or other disease;

          -  Post trauma or post surgery where there was total or partial removal of the breast
             resulting in significant deformity;

          -  Severe ptosis requiring reconstruction;

          -  Any congenital or acquired discrepancy in breast size such as to represent a
             significant physical deformity.

          -  Adequate tissue available to cover implants.

          -  Saline-filled implants are not an appropriate choice.

        Exclusion Criteria:

          -  Advanced fibrocystic disease considered to be premalignant without accompanying
             subcutaneous mastectomy.

          -  Existing carcinoma of the breast, without mastectomy.

          -  Abscess of infection in the body at the time of enrollment.

          -  Pregnant or nursing.

          -  Have any disease, including uncontrolled diabetes, which is clinically known to impact
             wound healing ability.

          -  Show tissue characteristics which are clinically incompatible with mammaplasty.

          -  Have, or under treatment for any condition which, in the opinion of the surgeon, may
             constitute an unwarranted surgical risk.

          -  Are not willing to undergo further surgery for revision, if medically required.

          -  Diagnosis of lupus or scleroderma.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 3, 2008</study_first_submitted>
  <study_first_submitted_qc>June 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 5, 2008</study_first_posted>
  <results_first_submitted>December 30, 2013</results_first_submitted>
  <results_first_submitted_qc>December 30, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 12, 2014</results_first_posted>
  <last_update_submitted>October 6, 2014</last_update_submitted>
  <last_update_submitted_qc>October 6, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Revision of augmentation or reconstruction</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Reconstruction</title>
          <description>Women who have undergone Breast Reconstruction</description>
        </group>
        <group group_id="P2">
          <title>Revision</title>
          <description>Women who have undergone Revision of a Breast Augmentation or Reconstruction</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="45055"/>
                <participants group_id="P2" count="39274"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42214"/>
                <participants group_id="P2" count="36766"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2841"/>
                <participants group_id="P2" count="2508"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Reconstruction</title>
          <description>Women who have undergone Breast Reconstruction</description>
        </group>
        <group group_id="B2">
          <title>Revision</title>
          <description>Women who have undergone Revision of a Breast Augmentation or Reconstruction</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="45055"/>
            <count group_id="B2" value="39274"/>
            <count group_id="B3" value="84329"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=17 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="115"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="119"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 69 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43304"/>
                    <measurement group_id="B2" value="37612"/>
                    <measurement group_id="B3" value="80916"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=70 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1065"/>
                    <measurement group_id="B2" value="1039"/>
                    <measurement group_id="B3" value="2104"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Not provided</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="571"/>
                    <measurement group_id="B2" value="619"/>
                    <measurement group_id="B3" value="1190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45055"/>
                    <measurement group_id="B2" value="39274"/>
                    <measurement group_id="B3" value="84329"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Local Complications</title>
        <description>By patient risk of complications occurring in at least 5% of patients in 1 or more cohorts</description>
        <time_frame>5 years</time_frame>
        <population>All enrolled patients</population>
        <group_list>
          <group group_id="O1">
            <title>Reconstruction</title>
            <description>Women who have undergone Breast Reconstruction</description>
          </group>
          <group group_id="O2">
            <title>Revision</title>
            <description>Women who have undergone Revision of a Breast Augmentation or Reconstruction</description>
          </group>
        </group_list>
        <measure>
          <title>Local Complications</title>
          <description>By patient risk of complications occurring in at least 5% of patients in 1 or more cohorts</description>
          <population>All enrolled patients</population>
          <units>Percentage by Patient</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45055"/>
                <count group_id="O2" value="39274"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Capsular Contracture</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.0" lower_limit="14.4" upper_limit="15.6"/>
                    <measurement group_id="O2" value="21.6" lower_limit="20.8" upper_limit="22.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asymmetry</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.1" lower_limit="10.6" upper_limit="11.7"/>
                    <measurement group_id="O2" value="10.7" lower_limit="10.1" upper_limit="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Implant Palpability/Visibility</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.1" lower_limit="6.7" upper_limit="7.6"/>
                    <measurement group_id="O2" value="11.4" lower_limit="10.9" upper_limit="12.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Implant Malposition</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.5" lower_limit="6.1" upper_limit="6.9"/>
                    <measurement group_id="O2" value="7.1" lower_limit="6.7" upper_limit="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Wrinkling</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.6" lower_limit="5.2" upper_limit="6.0"/>
                    <measurement group_id="O2" value="8.9" lower_limit="8.4" upper_limit="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Breast Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" lower_limit="4.8" upper_limit="5.5"/>
                    <measurement group_id="O2" value="6.6" lower_limit="6.1" upper_limit="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale</title>
        <description>Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied</description>
        <time_frame>5 years</time_frame>
        <population>All patients who had a breast implant satisfaction rating</population>
        <group_list>
          <group group_id="O1">
            <title>Reconstruction</title>
            <description>Women who have undergone Breast Reconstruction</description>
          </group>
          <group group_id="O2">
            <title>Revision</title>
            <description>Women who have undergone Revision of a Breast Augmentation or Reconstruction</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale</title>
          <description>Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied</description>
          <population>All patients who had a breast implant satisfaction rating</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7426"/>
                <count group_id="O2" value="5691"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Physician Satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" spread="0.9"/>
                    <measurement group_id="O2" value="4.3" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Patient Satisfaction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" spread="0.9"/>
                    <measurement group_id="O2" value="4.3" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Reconstruction</title>
          <description>Women who have undergone Breast Reconstruction</description>
        </group>
        <group group_id="E2">
          <title>Revision</title>
          <description>Women who have undergone Revision of a Breast Augmentation or Reconstruction</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45055"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="39274"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="45055"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="39274"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>A disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 90 days from the time submitted to the sponsor for review. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Medical Monitor</name_or_title>
      <organization>Allergan, Inc.</organization>
      <phone>714-246-4500</phone>
      <email>clinicaltrials@allergan.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

